Purdue Pharma L.P. engages in the research, development, production, sales, and licensing of prescription and non-prescription medicines and hospital products. It offers non-prescription products, which include laxatives for constipation and stool softening; microbicides for antiseptic protection; and nutraceuticals. The company also provides magnesium chloride supplements, active pharmaceutical ingredients, glycerin suppositories, and prescription medicines in the form of tablets and capsules. In addition, it offers educational materials and programs relating to pain management. Further, the company engages in non-clinical drug safety evaluation, formulations, analytical support, and pharmacokinetics/drug metabolism functions. It serves healthcare providers, patients, and caregivers. The company offers its products through distributors in the United States. The company was formerly known as Purdue Frederick Company, Inc. and it changed its name in 1991. Purdue Pharma L.P. was founded in 1892 and is headquartered in Stamford, Connecticut with a research lab in Cranbury, New Jersey. The company has manufacturing facilities in Wilson, North Carolina; Totowa, New Jersey; and Coventry, Rhode Island.
